Cargando…
A novel insulin formulation with a more rapid onset of action
AIMS/HYPOTHESIS: This study evaluates the pharmacodynamic and pharmacokinetic properties of the novel ultra-fast insulin product VIAject, a formulation of human soluble insulin and generally recognised as safe ingredients designed to increase the rate of absorption. METHODS: We performed five euglyc...
Autores principales: | Steiner, S., Hompesch, M., Pohl, R., Simms, P., Flacke, F., Mohr, T., Pfützner, A., Heinemann, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516197/ https://www.ncbi.nlm.nih.gov/pubmed/18641968 http://dx.doi.org/10.1007/s00125-008-1095-8 |
Ejemplares similares
-
Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
por: Morrow, Linda, et al.
Publicado: (2013) -
Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes
por: Forst, Thomas, et al.
Publicado: (2010) -
Development of an Analytical Method for the Rapid Quantitation of Peptides Used in Microbicide Formulations
por: Chen, Yufei, et al.
Publicado: (2014) -
Supramolecular approaches for insulin stabilization without prolonged duration of action
por: Meudom, Rolande, et al.
Publicado: (2023) -
Biosimilar insulins: guidance for data interpretation by clinicians and users
por: Heinemann, L., et al.
Publicado: (2015)